About Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
During the past decade, Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
According to Clinical.Site data, the most researched conditions in "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie" are
"Malignant Melanoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie" in a lesser frequency.
Clinical Trials Intervention Types at Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
Most popular intervention types in "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Chemotherapy (Induction Period)" (1 trials), "Rituximab" (1 trials) and "Vemurafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
The vast majority of trials in "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie" are
2 trials for "All" genders.
Clinical Trials Status at Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie
Currently, there are NaN active trials in "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".